Showing 6,081 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

HIV treatment

Atazanavir Detailed information

About HIV
September 2021
HIV treatment

Zidovudine Detailed information

About HIV
September 2021
HIV treatment

Zidovudine Factsheet

About HIV
September 2021
Bad science & bogus treatments

Dear Governor Kemp: There Is No AIDS Vaccine

Editor's pick
POZ
22 September 2021
Injectable & long-acting HIV treatment

Theratechnologies Announces Positive Results for Trogarzo® IV Push Administration Study

Editor's pick
GlobeNewswire
22 September 2021
HIV treatment

Ritonavir Factsheet

About HIV
September 2021
Kidney problems

People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP

News
21 September 2021
New & experimental HIV treatments

Exavir Therapeutics announces publication of preclinical data for novel tenofovir prodrug, XVIR-210, in Nature Communications, demonstrating long-acting exposures sufficient for antiviral activity against HIV and HBV

Editor's pick
GlobeNewswire
20 September 2021
PrEP science

One dose of TAF every three days gets more drug into cells than a daily dose of TDF

News
17 September 2021
Clinical trials

Thinking about joining a clinical trial?

About HIV
September 2021
Starting treatment

Dolutegravir more likely to suppress very high viral loads than other recommended first-line drugs

News
14 September 2021
PrEP science

First-in-Class NRTTI Demonstrates Potential as Long-Acting Oral PrEP Against HIV

Editor's pick
Contagion Live
13 September 2021
HIV treatment

How treatment works Illustrated

About HIV
September 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
Clinical trials

Treatment interruption in cure research is associated with greater risk of non-AIDS related events in the long term, Spanish study finds

News
7 September 2021
HIV treatment

Nevirapine Detailed information

About HIV
August 2021
HIV treatment

Nevirapine Factsheet

About HIV
August 2021
HIV treatment

Abacavir/lamivudine Detailed information

About HIV
August 2021
HIV treatment

Abacavir/lamivudine Factsheet

About HIV
August 2021
HIV treatment

Lamivudine Detailed information

About HIV
August 2021
HIV treatment

Emtricitabine (Emtriva) Detailed information

About HIV
August 2021
HIV treatment

Abacavir Detailed information

About HIV
August 2021
HIV treatment

Abacavir Factsheet

About HIV
August 2021
Adherence

Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions

News
20 August 2021